Correlation Between Merck and Davis Series

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Davis Series at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Davis Series into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Davis Series , you can compare the effects of market volatilities on Merck and Davis Series and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Davis Series. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Davis Series.

Diversification Opportunities for Merck and Davis Series

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Merck and Davis is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Davis Series in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Davis Series and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Davis Series. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Davis Series has no effect on the direction of Merck i.e., Merck and Davis Series go up and down completely randomly.

Pair Corralation between Merck and Davis Series

Considering the 90-day investment horizon Merck is expected to generate 121.21 times less return on investment than Davis Series. But when comparing it to its historical volatility, Merck Company is 17.67 times less risky than Davis Series. It trades about 0.01 of its potential returns per unit of risk. Davis Series is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  96.00  in Davis Series on September 4, 2024 and sell it today you would earn a total of  4.00  from holding Davis Series or generate 4.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy99.6%
ValuesDaily Returns

Merck Company  vs.  Davis Series

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Davis Series 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Davis Series are ranked lower than 9 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Davis Series is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Merck and Davis Series Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Davis Series

The main advantage of trading using opposite Merck and Davis Series positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Davis Series can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Davis Series will offset losses from the drop in Davis Series' long position.
The idea behind Merck Company and Davis Series pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Correlations
Find global opportunities by holding instruments from different markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stocks Directory
Find actively traded stocks across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance